Kronox Lab Sciences Ltd

Kronox Lab Sciences Ltd

₹ 212 1.01%
13 Dec - close price
About

Incorporated in 2008, Kronox Lab Sciences Ltd manufactures High Purity Fine, inorganic chemicals, phosphate, and metallic chemicals[1]

Key Points

Business Overview:[1][2]
KLSL is in High Purity Speciality Fine Chemicals Business with portfolio of about 185 products including Excipients and ingredients, High Purity Reagents, Pharmaceutical, nutraceutical and Food Chemical.

  • Market Cap 787 Cr.
  • Current Price 212
  • High / Low 229 / 138
  • Stock P/E 33.7
  • Book Value 20.8
  • Dividend Yield 0.24 %
  • ROCE 51.5 %
  • ROE 38.4 %
  • Face Value 10.0

Pros

  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 39.0%

Cons

  • Stock is trading at 10.2 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Part of BSE IPO

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
21.47 25.95 21.02 20.71 22.18 25.19 24.86
17.48 17.43 15.16 14.40 14.33 16.98 16.06
Operating Profit 3.99 8.52 5.86 6.31 7.85 8.21 8.80
OPM % 18.58% 32.83% 27.88% 30.47% 35.39% 32.59% 35.40%
0.14 0.24 0.49 0.42 0.83 0.43 0.36
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.30 0.32 0.38 0.30 0.29 0.33 0.34
Profit before tax 3.83 8.44 5.97 6.43 8.39 8.31 8.82
Tax % 36.55% 24.53% 27.14% 24.57% 29.92% 25.99% 26.64%
2.44 6.38 4.35 4.84 5.88 6.15 6.47
EPS in Rs 0.66 1.72 1.17 1.30 1.58 1.66 1.74
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
50 62 82 96 90 93
39 48 63 74 62 62
Operating Profit 12 15 20 22 28 31
OPM % 23% 24% 24% 23% 32% 34%
1 1 1 2 2 2
Interest 0 0 0 0 0 0
Depreciation 1 2 2 2 1 1
Profit before tax 12 13 18 22 29 32
Tax % 27% 26% 26% 26% 25%
9 10 14 16 21 23
EPS in Rs 343.60 403.73 565.56 4.42 5.75 6.28
Dividend Payout % 0% 0% 0% 0% 9%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 13%
TTM: -6%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 30%
TTM: 30%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 39%
Last Year: 38%

Balance Sheet

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 0.25 0.24 0.24 37 37 37
Reserves 23 27 40 8 29 40
0 4 3 0 0 0
11 7 13 9 8 8
Total Liabilities 34 38 57 54 74 85
6 9 11 16 26 26
CWIP 0 0 0 0 0 2
Investments 0 0 0 0 0 0
29 28 45 38 47 57
Total Assets 34 38 57 54 74 85

Cash Flows

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
4 11 9 20 17
-4 -3 -8 -7 -17
-0 -7 -1 -13 0
Net Cash Flow 0 1 1 -0 0

Ratios

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 110 90 114 71 72
Inventory Days 70 58 58 61 74
Days Payable 102 69 89 52 50
Cash Conversion Cycle 78 79 84 80 96
Working Capital Days 100 100 128 83 143
ROCE % 50% 51% 50% 52%

Shareholding Pattern

Numbers in percentages

2 Recently
Jun 2024Sep 2024
74.21% 74.21%
1.56% 0.56%
4.34% 2.57%
19.89% 22.66%
No. of Shareholders 32,60439,792

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents